FSHR and ovarian carcinoma: Several GPCRs are overexpressed in ovarian cancer including the lysophosphatidic acid receptor (LPAR), C-X-C chemokine receptor type 4 (CXCR4), follicle-stimulating hormone receptor (FSHR) and luteinizing hormone/choriogonadotropin receptor (LHCGR) (Khetan et al., 2022).